Sandwich, United Kingdom

Michael Leslie Hughes

This inventor holds 2 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2001-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Leslie Hughes. Retrieved from https://idiyas.com/inventor/michael-leslie-hughes

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Location History:

  • Sandwich, GB (2001)
  • Kingsdown Deal, GB (2002)

Company Filing History:


Years Active: 2001-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Leslie Hughes: Innovator in Therapeutic Agents

Introduction

Michael Leslie Hughes is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of therapeutic agents, holding a total of 2 patents. His work focuses on innovative solutions that enhance the efficacy of medical treatments.

Latest Patents

One of his latest patents is titled "Crystalline polymorphic form of (S,S,S)-N-(1-[2-carboxy-3 (N2-mesyllyslamino) propyl]-1-cyclopentylcarbonyl) tyrosine." This invention relates to a crystalline, α-polymorphic form of a compound and includes processes for its preparation, intermediates used in the preparation, compositions containing it, and its various uses.

Career Highlights

Michael is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development of innovative therapeutic solutions that aim to improve patient outcomes.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues, including Richard Anthony Storey and Peter James Dunn. These collaborations have further enriched his research and contributed to the advancement of therapeutic agents.

Conclusion

Michael Leslie Hughes is a distinguished inventor whose work in therapeutic agents has led to valuable patents and collaborations. His contributions continue to impact the field of medicine positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…